Showing results (451-460 of 486) with videos related to

Sort By:
Pageof 49
Hepatology Communications|October 27, 2023
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational studyVincent Joerg, Bernhard Scheiner, Antonio D Alessio, et al.
Immunity|January 11, 2023
T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasisDaria Briukhovetska, Javier Suarez-Gosalvez, Cornelia Voigt, et al.
Journal of Hepatology|December 31, 2023
IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 inductionAhmad Mustafa Shiri, Tao Zhang, Tanja Bedke, et al.
Nature Genetics|December 15, 2010
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility lociEspen Melum, Andre Franke, Christoph Schramm, et al.
Gastroenterology|April 29, 2014
Genome-wide association study identifies variants associated with autoimmune hepatitis type 1Ynto S de Boer, Nicole M F van Gerven, Antonie Zwiers, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 10, 2022
Impact on follow-up strategies in patients with primary sclerosing cholangitisAnnika Bergquist, Tobias J Weismüller, Cynthia Levy, et al.
JHEP Reports : Innovation in Hepatology|April 7, 2023
Treating hepatitis D with bulevirtide - Real-world experience from 114 patientsChristopher Dietz-Fricke, Frank Tacke, Caroline Zöllner, et al.
Cancers|December 23, 2022
A Critical Role of the IL-22-IL-22 Binding Protein Axis in Hepatocellular CarcinomaAnastasios D Giannou, Jöran Lücke, Dörte Kleinschmidt, et al.
Nature Metabolism|March 29, 2022
Molecular consequences of SARS-CoV-2 liver tropismNicola Wanner, Geoffroy Andrieux, Pau Badia-I-Mompel, et al.
Pageof 49